More importantly, high ADCY6 expression and low methylation in breast cancer patients is correlated with better prognosis, and the activation of signalling pathways, immune checkpoint receptors and ligands related to the immune process is negatively correlated (21). The gene discussed is ADCY6; the disease is breast carcinoma.